| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael F Giordano is Director at RAPT. Michael F Giordano's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Michael F Giordano has 11 Form 4 filings on record from October 2019 to March 2026, all as Director at RAPT Therapeutics (RAPT), 2019–2026.
The 22 reported transactions were 9 dispositions back to the company, 8 option or other derivative awards, 2 option exercises and 1 tender, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $634K.
The only open-market sale was 19,013 shares of RAPT at an average $33.37 on June 25, 2020, about $634K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Sale+OE | 19,013 | $33.37 | $634,463.81 | - |